CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Exercise or conversion Executive VP & CFO acquired 706 shares (option exercise)
- 4 Open-market sale Director sold 250 shares at $509.70 ($127,425)
- 4 Shares withheld for taxes EVP, GC & Corp. Secretary gave up 253 shares (to pay taxes)
- 4 Shares withheld for taxes Senior Vice President gave up 252 shares (to pay taxes)
- 4 Shares withheld for taxes Senior Vice President gave up 295 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Executive Vice President gave up 235 shares (to pay taxes)
- 4 Shares withheld for taxes Executive VP & CFO gave up 964 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 1,423 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 1 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 204 shares (to pay taxes)
- 4 Gift Director gave 660 shares (gift)
- 4 Grant or award Director acquired 13 shares (grant or award)
- 4 Grant or award Director acquired 49 shares (grant or award)
- 4 Grant or award Director acquired 41 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Executive Vice President sold 4,595 shares at $633.00 ($2,908,635)
- 4 Gift Director gave 1,560 shares (gift)
- 4 Open-market sale Executive VP & CFO sold 9,225 shares at an average $620.73 ($5,726,188)
- 4 Open-market sale Executive VP & CFO sold 20,000 shares at an average $624.96 ($12,499,279)
Page 13 of 74 · 1,467 filings